Matching articles for "mammography"

Cancer Screening

   
The Medical Letter on Drugs and Therapeutics • December 1, 2012;  (Issue 124)
Use of screening tests to identify cancers before they cause symptoms can lead to earlier therapy and may improve outcomes. Screening tests for some common cancers are reviewed...
Use of screening tests to identify cancers before they cause symptoms can lead to earlier therapy and may improve outcomes. Screening tests for some common cancers are reviewed below.
Treat Guidel Med Lett. 2012 Dec;10(124):87-94 | Show Full IntroductionHide Full Introduction

BRCA Screening

   
The Medical Letter on Drugs and Therapeutics • November 19, 2007;  (Issue 1274)
Direct-to-consumer advertisements are urging women to be tested for mutations in BRCA1 and BRCA2 genes, which are the most common known causes of an inherited predisposition to breast and ovarian cancer....
Direct-to-consumer advertisements are urging women to be tested for mutations in BRCA1 and BRCA2 genes, which are the most common known causes of an inherited predisposition to breast and ovarian cancer. Clinically important BRCA mutations have been found in about 2% of Ashkenazi Jewish women, and are estimated to occur in about 1 in 300 to 500 women in the general non-Jewish US population. The prevalence appears to be lower in non-whites.
Med Lett Drugs Ther. 2007 Nov 19;49(1274):93-4 | Show Full IntroductionHide Full Introduction

Screening Tests for Cancer

   
The Medical Letter on Drugs and Therapeutics • September 1, 2005;  (Issue 37)
Use of screening tests to identify cancers before they cause symptoms can lead to earlier therapy and may improve outcomes. Screening tests for some common cancers are...
Use of screening tests to identify cancers before they cause symptoms can lead to earlier therapy and may improve outcomes. Screening tests for some common cancers are reviewed.
Treat Guidel Med Lett. 2005 Sep;3(37):63-8 | Show Full IntroductionHide Full Introduction